Loading Page..

Knowledge Content Library

260
Project Derailed? Finding Timeline Drivers to Get Back on Track
Presented by Johnson (Decision Strategies) at 2010 DAAG Conference in Orlando. Example of modeling project duration and using sensitivity analyses to focus on key factors.

261
Strategy, Portfolio & Risk Management: A Value-driven ERM Perspective
Presented by Strategic Decisions Group at 2010 DAAG Conference in Orlando. Overview of the key factors and challenges in Enterprise Risk Management.

262
Insights from the Brain Sciences for Decision Professionals
Presented by Carl Spetzler (Strategic Decisions Group) at 2010 DAAG Conference in Orlando. Recent technological advances in brain imaging and insights into brain functioning provide new opportunities for uncovering the neurological underpinnings of mental functions including decision making.

263
Nassim Taleb’s Black Swan and Decision Analysis
Presented by Jack Kloeber (Kromite) at 2010 DAAG Conference in Orlando. Discussion of Black Swan phenomena and how to incorporate into Decision Analysis.

247
Using Decision Analysis to Select Communications Research Projects
Presented by Hal Wilson (National Security Agency) and Don Buckshaw (Innovative Decisions) at 2010 DAAG Conference in Orlando. Portfolio analysis example in DoD discussing how to mix hard skills (multi-objective models) with soft skills (negotiations and gaining customer buy-in).

248
Making Trade Space: Value Models and Enterprise Capability Analysis for the U.S. Intelligence Community
Presented by Freeman Marvin (Innovative Decisions) at 2010 DAAG Conference in Orlando. Application of decision analysis methods to improving US Intelligence Community enterprise capability analysis during the first five years of the Office of the Director of National Intelligence (ODNI).

249
Improving the process of balancing benefits and risks in approving drugs
Presented by Lawrence D. Phillips (London School of Economics and Political Science) at 2010 DAAG Conference in Orlando. Discussion of benefit risk methods in drug development, and example applied to H1N1 flu vaccine.

250
Quantitative benefit-risk assessment: An analytical framework for a shared understanding of the effects of medicines
Presented by Patrick Ryan (GlaxoSmithKline) at 2010 DAAG Conference in Orlando. Discussion of benefit risk methods in GlaxoSmithKline.

251
Building Organizational Decision Quality
Presented by Carl Spetzler (Strategic Decisions Group) at 2010 DAAG Conference in Orlando. Discussion of building and measuring organizational decision quality (ODQ), including survey results of leading companies.

252
A Pilot Risk Analysis Study for an IBM Services Delivery Location
Presented by Bonnie Ray and Debarun Bhattacharjya (IBM) at 2010 DAAG Conference in Orlando. Discussion of pilot study to quantitatively assess risks and potential impacts on IBM Services Delivery resources located in India to drive improved long term resource planning.

253
Decision Analysis for New Atherosclerosis Drug: Assessing Consistent Probabilities of Success for Drug Development Decision Analysis
Presented by Dave Swank (BristolMyersSquibb) at 2010 DAAG Conference in Orlando. Discussion of probability assessment and the use of sensitivity analysis to look for robustness in assessments.

254
Impact of Manufacturing Strategy On Portfolio Prioritization
Presented by Jerry Ruhland (Baxter) at 2010 DAAG Conference in Orlando. Example of incorporating analysis of manufacturing strategies into portfolio process.

255
Convince or Persuade?
Presented by Ron Howard (Stanford) at 2010 DAAG Conference in Orlando. Discusses how a decision analyst's job is to provide people with an argument that will allow them to convince themselves

245
An R&D Asset Development Decision Utilizing Lilly’s Quality Decision Process
Presented by Charles Persinger (Eli Lilly) at 2009 DAAG Conference in Indianapolis. Description of Lilly's decision process.

246
The Joint Improvised Explosive Device Defeat Organization (JIEDDO) Proposal Value Model
Presented by Jeff Weir, Ken Bauer, Shane Knighton (Air Force) at 2009 DAAG Conference in Indianapolis. Multi-criteria decision analytic methods applied to selection of methods to defeat improvised explosive devices.

242
Quantitative Benefit-Risk
Presented by James Felli (Eli Lilly) at 2009 DAAG Conference in Indianapolis. Discussion of Lilly's quantitative benefit-risk model based on multi-criteria decision analytic methods.

243
Frame size matters in the public debate on mammography
Presented by Marilyn Metcalf at 2009 DAAG Conference in Indianapolis. Discussion of problem framing and its importance as more patients are drawn into the decision making process.

244
Using the Hippocratic Oath to Provide a Surrogate for Client Utility Functions
Presented by Robert F. Bordley (General Motors) at 2009 DAAG Conference in Indianapolis. Example of how the Hippocratic Oath can be an accessible way to get at utility functions for some clients and patients.

239
From Discovery to Successful Implementation Predicting Organizational Change Preparedness
Presented by Phillip Decker (University of Houston) with Pat Leach, Christie McCormack, and David Skinner (Decision Strategies) at 2009 DAAG Conference in Indianapolis. Discussion of organizational change management and its relationship to the success during implementation of projects.

240
IT Investments can be Compared to Other Investments
Presented by Jerry Lieberman (Decision Strategies) at 2009 DAAG Conference in Indianapolis. Discussion of how to capture the value of IT, comparable to other business investments.

Stay connected